Wockhardt shares have soared to an 8-year high of Rs 1,212.55, reflecting a remarkable 384% increase since November 10, 2023.

Beta Bionics has launched the integration of its flagship iLet Bionic Pancreas with Abbott’s FreeStyle Libre 3 Plus sensor.

The regulatory milestone unlocks access for U.S. care providers and health systems to leading-edge diabetes care technology demonstrated to increase patients' adherence and reduce cost of treatment ...

Biosimilars offer significant cost-saving potential while expanding patient access, particularly in oncology and immunology.

Wegovy and similar weight-loss medications are becoming widely prescribed for teenagers with obesity, but little is known ...

What you need to know More than 500 million people live with diabetes, and around 783 million are expected to have the ...

Type 2 diabetics taking the drug had a lower risk of Alzheimer’s compared to patients on other diabetes drugs Semaglutide is ...

E*TRADE excels even outside of its $0 commissions, with superb educational resources, portfolio-building tools and a large mutual fund selection. Many, or all, of the products featured on this ...

Now, scientists have made a major breakthrough in developing what has been long called the “holy grail” diabetes treatments — a “smart” insulin that responds in real time to fluctuations in one’s ...

“Under the Trump Administration’s model, participating plans were not required to cover all insulin products at the $35 monthly copayment amount, just one of each dosage form (vial ...

Reference: “Durable effects of duodenal ablation using electroporation combined with semaglutide to eliminate insulin therapy in patients with type-2 diabetes; the 24-month results.” C.B.E Busch et al ...